Literature DB >> 1434656

Transhiatal and transthoracic esophagectomy: a comparative study.

J S Bolton1, A Sardi, J C Bowen, J K Ellis.   

Abstract

From January 1981 to December 1990, 55 consecutive patients underwent esophageal resection by either the transhiatal (THE, 26 patients) or transthoracic (TTE, 29 patients) approach. Patient age, tumor size, and tumor stage were similar in the two groups. THE patients had a significantly worse mean preoperative American Society of Anesthesiologists (ASA) risk class assigned by the anesthesiologist. Patients who underwent THE had a significantly lower operative mortality and rate of cardiopulmonary complications, significantly shorter intensive care unit and hospital length of stay, and a significantly better postoperative survival when operative deaths are included in the analysis. Operative deaths in the TTE group were concentrated among patients > 65 years of age (4 of 9 died), in an ASA risk class > or = III (3 of 7 died) or with moderate or severe cardiac or pulmonary impairment preoperatively (4 of 6 died).

Entities:  

Mesh:

Year:  1992        PMID: 1434656     DOI: 10.1002/jso.2930510410

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Intratracheal long-term pH monitoring: a new method to evaluate episodes of silent acid aspiration in patients after esophagectomy and gastric pull up.

Authors:  Werner K H Kauer; Hubert J Stein; Holger Bartels; J Rüdiger Siewert
Journal:  J Gastrointest Surg       Date:  2003 Jul-Aug       Impact factor: 3.452

Review 2.  Esophagectomy from then to now.

Authors:  Caitlin Takahashi; Ravi Shridhar; Jamie Huston; Kenneth Meredith
Journal:  J Gastrointest Oncol       Date:  2018-10

3.  Transhiatal esophagectomy: clinical experience and refinements.

Authors:  M B Orringer; B Marshall; M D Iannettoni
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

Review 4.  Transhiatal esophagectomy for treatment of benign and malignant esophageal disease.

Authors:  M B Orringer; B Marshall; M D Iannettoni
Journal:  World J Surg       Date:  2001-02       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.